BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Uys MM, Shahid M, Sallinen J, Harvey BH. The α2C-adrenoceptor antagonist, ORM-10921, exerts antidepressant-like effects in the Flinders Sensitive Line rat. Behav Pharmacol 2017;28:9-18. [PMID: 27749317 DOI: 10.1097/FBP.0000000000000261] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
Number Citing Articles
1 Tekin N, Karamahmutoğlu TE, Aykaç A, Akakın D, Gören MZ. The α2C-adrenoceptor antagonist JP-1302 controls behavioral parameters, tyrosine hydroxylase activity and receptor expression in a rat model of ketamine-induced schizophrenia-like deficits. Pharmacology Biochemistry and Behavior 2022. [DOI: 10.1016/j.pbb.2022.173490] [Reference Citation Analysis]
2 Wang S, Haikarainen A, Pohjakallio A, Sipilä J, Kaskinoro J, Juhila S, Jalava N, Koskinen M, Vesajoki M, Kumpulainen E, Pystynen J, Koskelainen T, Holm P, Din Belle D. Development of Benzodioxine-heteroarylpiperazines as Highly Potent and Selective α2c Antagonists. Bioorg Med Chem Lett 2022;:129005. [PMID: 36174834 DOI: 10.1016/j.bmcl.2022.129005] [Reference Citation Analysis]
3 Iglesias LP, Coelho AA, da Silva NR, Müller HK, Moreira FA, Wegener G, Joca S. Characterization of a novel gene-environment-based animal model to study resilience and susceptibility to PTSD and co-morbid depression.. [DOI: 10.1101/2022.09.14.507883] [Reference Citation Analysis]
4 Fitzgerald PJ. Are Noradrenergic Transmission Reducing Drugs Antidepressants? Front Behav Neurosci 2021;15:673634. [PMID: 34658805 DOI: 10.3389/fnbeh.2021.673634] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Rusu-Zota G, Burlui A, Rezus E, Paduraru L, Sorodoc V. Idazoxan and Efaroxan Potentiate the Endurance Performances and the Antioxidant Activity of Ephedrine in Rats. Medicina (Kaunas) 2021;57:194. [PMID: 33668888 DOI: 10.3390/medicina57030194] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Stein DJ, Daniels W, Harvey BH. Translational Medicine Strategies in PTSD Drug Development. Translational Medicine in CNS Drug Development 2019. [DOI: 10.1016/b978-0-12-803161-2.00026-6] [Reference Citation Analysis]
7 Uys MM, Shahid M, Harvey BH. Therapeutic Potential of Selectively Targeting the α2C-Adrenoceptor in Cognition, Depression, and Schizophrenia-New Developments and Future Perspective. Front Psychiatry 2017;8:144. [PMID: 28855875 DOI: 10.3389/fpsyt.2017.00144] [Cited by in Crossref: 39] [Cited by in F6Publishing: 42] [Article Influence: 7.8] [Reference Citation Analysis]